Orphan Drug Designation

PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News
FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News
FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status
Why Kymera Therapeutics Stock Is Gaining Wednesday
Lantern Pharma's LP-184 Receives Orphan Drug Tag For Brain Cancer Indication

Orphan Drug Designation Recent News

Allogene's BCMA-Targeted Therapy Gets US Orphan Drug Tag For Multiple Myeloma
C4 Therapeutics Multiple Myeloma Candidate Scores FDA Orphan Drug Tag
Lantern Pharma Secures FDA Orphan Drug Tag For Pancreatic Cancer Candidate
Akouos' Hearing Loss Gene Therapy Poised To Receive Orphan Drug Tag In Europe
Aldeyra Secures US Orphan Drug Tag For Its Retinitis Pigmentosa Candidate
Relief Therapeutics' Lead Candidate Gets US Orphan Drug Tag In Sarcoidosis
Aldeyra Stock Trading Higher On FDA Orphan Drug Tag For Primary Vitreoretinal Lymphoma Candidate
Soleno Stock Shoots Higher as Diazoxide Choline Gets US Orphan Drug Tag for Glycogen Storage Disease
Seelos's Amyotrophic Lateral Sclerosis Candidate, SLS-005 An Orphan Drug In Europe
Moleculin Biotech Stock Is Trading Higher After WP1066 Scores Rare Pediatric Disease Tag For Type Of Brain Tumor
Why Surface Oncology Shares Spiked 19% Today
Shares of Surface Oncology Inc. (NASDAQ: SURF), a clinical-stage biopharma company, gained more than 19% in the extended session on Tuesday.
BridgeBio Pharma Gets First FDA-Approval For Rare Genetic Metabolic Disorder
BridgeBio Pharma Inc (NASDAQ: BBIO) and affiliate Origin Biosciences Inc have received the 
AIM ImmunoTech Gets Orphan Drug Tag For Ampligen In Pancreatic Cancer
Cerecor's CERC-803 Nabs US Orphan Drug Tag In Rare Immunodeficiency Disorder
Shares Of Pluristem Therapeutics Surging Following Receipt Of Orphan Drug Designation
Why Shares of Ignyta Are Trading Higher

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved